Stock listing
KNE Stock Price, News, Filings & Events — Kane Biotech Inc.
Selected listing: KNE · NEO · CAD · CA
This page tracks Kane Biotech Inc.'s KNE:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KNE:NEO. KNE:NEO is the stock-level entry point for investors researching Kane Biotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kane Biotech Inc. is a public company listed under the ticker KNE on the Canadian market. The company has a market capitalization of approximately CAD 3.65 million. Kane Biotech focuses on developing innovative solutions for the prevention and treatment of biofilm-related infections.
- Ticker
- KNE:NEO
- Asset type
- Stock
- Market cap
- $4.4M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NEO
- Currency
- CAD
Kane Biotech Inc. KNE:NEO stock context
This page tracks Kane Biotech Inc.'s KNE:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KNE:NEO. KNE:NEO is the stock-level entry point for investors researching Kane Biotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kane Biotech Inc. is a public company listed under the ticker KNE on the Canadian market. The company has a market capitalization of approximately CAD 3.65 million. Kane Biotech focuses on developing innovative solutions for the prevention and treatment of biofilm-related infections.
Latest news from Kane Biotech Inc.
Kane Biotech to Host Commercial Update Webcast on September 16
September 9, 2026
Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.
September 2, 2026
Kane Biotech Announces Second Quarter 2026 Financial Results
August 27, 2026
Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium
August 25, 2026
Kane Biotech Announces Engagement of DNA Advisors
August 5, 2026
Kane Biotech Inc. earnings calls
Kane Biotech Inc Ord (KNBIF) Q3 2024 Earnings Call
December 3, 2024 · Replay with transcript and chapters
Kane Biotech Inc Ord (KNBIF) Q2 2024 Earnings Call
August 29, 2024 · Replay with transcript and chapters
Kane Biotech Inc Ord (KNBIF) Q1 2024 Earnings Call
May 22, 2024 · Replay with transcript and chapters
Kane Biotech Inc Ord (KNBIF) Q4 2023 Earnings Call
March 26, 2024 · Replay with transcript and chapters
Kane Biotech Inc Ord (KNBIF) Q2 2023 Earnings Call
August 29, 2023 · Replay with transcript and chapters
Kane Biotech Inc Ord (KNBIF) Q1 2023 Earnings Call
May 25, 2023 · Replay with transcript and chapters
Research Kane Biotech Inc.
Kane Biotech Inc. investor report
Review AI stock analysis and investor report context for KNE:NEO.
Kane Biotech Inc. company profile
View the public company page for Kane Biotech Inc. on 6ix.
Kane Biotech Inc. news
Read company news and market updates connected to Kane Biotech Inc..
Kane Biotech Inc. investor events
Find investor webinars, events, and replay context for Kane Biotech Inc..